Skip to main content

Ayurvedic Drug Manufacturers’ Association will meet to commerce ministry to discuss issues on ABS levy

academics

 

Clinical research courses

Ayurvedic Drug Manufacturers’ Association (ADMA) is planning to meet the commerce ministry next week to get some relief on the obligation to pay heavy access benefit sharing (ABS) levy.

Industry wants the government to totally exempt the traditional sector like the Ayurveda and herbal industry from the ambit of ABS tax. It is inequitable for the industry to face this access tax at their struggling time. By this step government making the helplessness . The government should also take requisite steps to at least exempt small and medium scale units from tax. ADMA has been taking all the necessary steps to counter the claims and impress the government officials on the challenges and problems faced by the industry on this matter.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>